| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.3 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |